Recall Z-1917-2015— HeartWare Inc
Class II · Ongoing
Class II FDA medical device recall by HeartWare Inc, initiated 2015-04-29. FDA's recall record names no specific 510(k) clearance for this event. Product: HeartWare Ventricular Assist System (HVAD) For use as a bridge-to-cardiac transplantation in patient who are at risk of death from refractory end-stage left ventricular heart failure.. Reason: Complaints with the HVAD Abnormal Power Source Switching..
- Recalling firm
- HeartWare Inc
- Classification
- Class II
- Status
- Ongoing
- Initiated
- 2015-04-29
- Firm location
- Miami Lakes, FL, United States
Product description
HeartWare Ventricular Assist System (HVAD) For use as a bridge-to-cardiac transplantation in patient who are at risk of death from refractory end-stage left ventricular heart failure.
Reason for recall
Complaints with the HVAD Abnormal Power Source Switching.
Data sourced from openFDA. This site is unofficial and independent of the FDA.